Deep learning—a form of artificial intelligence capable of improving itself with limited user input—has radically reshaped the landscape of biomedical research since its emergence in the early 2010s.

- TAPS+ enables simultaneous detection of methylation and genetic variants, unlocking new insights for precision oncology and translational research. - Preserves DNA integrity in challenging ...

Deep Genomics is taking two emerging technologies—which in recent years have captured the public’s attention for different reasons—and is finding they can work great together. The company has put ...

TORONTO--(BUSINESS WIRE)--Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced today that its founder and Chief Innovation ...

In today’s fast-moving biopharma landscape, companies face increasing pressure to deliver the right treatment, to the right patient, at the right time, faster and more efficiently. As our ...

TORONTO--(BUSINESS WIRE)--Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced today the release of the manuscript, “An RNA ...

Advanced deep learning (DL) and large language models (LLMs) decode multimodal imaging-omics associations across modalities, scales, organs, and diseases. The framework enables interpretable analysis ...